Ernexa Therapeutics Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2010 | — | -6.6% | -7.4% |
| Sep 2010 | — | 2.4% | 1.9% |
| Mar 2011 | — | -8.7% | -9.3% |
| Jun 2011 | — | -17,347.6% | -16,210.9% |
| Sep 2011 | — | -13.5% | -14.3% |
| Dec 2011 | — | -14.9% | -17.0% |
| Mar 2012 | — | -16.4% | -17.2% |
| Jun 2012 | — | -10,689.9% | -10,523.7% |
| Sep 2012 | — | 1.6% | 0.9% |
| Dec 2012 | — | 8.1% | 10.6% |
| Mar 2013 | — | -6.0% | -6.0% |
| Jun 2013 | — | -2.1% | -1.8% |
| Sep 2013 | — | -4.3% | -4.2% |
| Mar 2014 | — | -10.2% | -10.1% |
| Jun 2014 | — | -18.9% | -19.6% |
| Sep 2014 | — | -21.2% | -21.9% |
| Mar 2015 | — | -38.5% | -39.5% |
| Jun 2015 | — | -39.9% | -42.4% |
| Sep 2015 | — | -21.6% | -22.2% |
| Mar 2016 | — | -15.8% | -19.0% |
| Jun 2016 | — | -12.9% | -15.7% |
| Sep 2016 | — | -7.6% | -10.5% |
| Mar 2017 | — | -15.9% | -1.7% |
| Jun 2017 | — | -0.5% | -3.0% |
| Sep 2017 | — | -1.0% | -3.5% |
| Mar 2018 | — | -5.4% | -7.1% |
| Jun 2018 | — | -0.5% | -2.2% |
| Sep 2018 | — | 6.2% | 3.7% |
| Mar 2019 | — | -4.5% | -6.5% |
| Jun 2019 | — | 0.0% | -1.7% |
| Sep 2019 | — | -6.9% | -7.7% |
| Mar 2020 | — | -42.4% | -42.6% |
| Jun 2020 | — | -267.8% | -269.7% |
| Sep 2020 | — | -135.9% | -136.8% |
| Sep 2023 | -135.3% | -10,794.1% | -10,962.7% |
| Mar 2024 | -29.8% | -12,312.8% | -14,142.6% |
| Jun 2024 | -102.1% | -10,491.5% | -11,763.8% |
| Sep 2024 | 112.3% | -463.9% | -5,462.8% |